COMMUNIQUÉS West-GlobeNewswire

Precipio Completes a $3M Convertible Debt Facility
23/04/2018
Management focuses on growth opportunities NEW HAVEN, Conn., April 23, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO ), announced today that it entered into a convertible debt [...]
Evolus to Present at the Inaugural Aesthetics Innovation Summit and ASAPS’ The Aesthetic Meeting
23/04/2018
Four Presentations to Discuss the State of the Neurotoxin Industry IRVINE, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS ) (“Evolus”), a lifestyle aesthetics company focused on delivering [...]
Paratek Pharmaceuticals Presents Data Supporting Potential Approval of Omadacycline for Treatment of Community-Acquired Bacterial Pneumonia Based on the EMA Guidelines at ECCMID
23/04/2018
Company on track to file marketing authorization applications in the European Union in the second half of 2018 Data on utility in geographic regions also presented MADRID, Spain, April 23, 2018 (GLOBE NEWSWIRE) -- [...]
Paratek Pharmaceuticals Presents New Microbiology Efficacy Data of Oral-only Omadacycline Against the Most Common Pathogens Associated with Skin Infections
23/04/2018
- First presentation of the OASIS-2 topline results - Sub-analysis examining efficacy of oral-only omadacycline on lesion size also presented at ECCMID 2018 MADRID, Spain, April 23, 2018 (GLOBE NEWSWIRE) -- Paratek [...]
Misonix to Present at the 43rd Annual Deutsche Bank Health Care Conference on May 8
23/04/2018
FARMINGDALE, N.Y., April 23, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON ) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
Melinta Therapeutics Presents Updates on the Pyrrolocytosine Compound RX-P2382 against ESKAPE Pathogens at ECCMID 2018
23/04/2018
NEW HAVEN, Conn., April 23, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]
Immunovaccine to Present at Bloom Burton & Co. Healthcare Investor Conference
23/04/2018
HALIFAX, Nova Scotia, April 23, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, announced that Chief Executive Officer Frederic Ors will present an update [...]
ObsEva Announces Upcoming Presentations Related to its Endometriosis and Uterine Fibroid Development Programs with its Novel Oral GnRH Receptor Antagonist OBE2109 (KLH-2109)
23/04/2018
Geneva, Switzerland and Boston, MA - 23 April 2018 - ObsEva SA (Nasdaq: OBSV), a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that [...]
Summit Highlights Discovery of New Mechanism Antibiotics for the Treatment of Gonorrhoea at ECCMID 2018
23/04/2018
Summit Therapeutics plc ("Summit" or the "Company") Summit Highlights Discovery of a Series of New Mechanism Antibiotics for the Treatment of Gonorrhoea in Late-Breaking Presentation at ECCMID 2018 Oxford, UK, and [...]
Kamada Received Feedback from FDA on Proposed Phase 3 Protocol for Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency Disease
23/04/2018
REHOVOT, Israel, April 23, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (the "Company") (Nasdaq: KMDA ) (TASE: KMDA ), a plasma-derived protein therapeutics company, today announced that the Company recently received feedback [...]
Zynerba Pharmaceuticals Announces Oral Presentation of ZYN002 Data at the 16th NFXF International Fragile X Conference in July 2018
23/04/2018
DEVON, Pa., April 23, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE ), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative [...]
Aclaris Therapeutics Announces First Patient Dosed in a Pilot Study with ATI-502 Topical in Patients with Androgenetic Alopecia
23/04/2018
WAYNE, Pa., April 23, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]
Summit Highlights Discovery of a Series of New Mechanism Antibiotics for the Treatment of Gonorrhoea in Late-Breaking Presentation at ECCMID 2018
23/04/2018
OXFORD, United Kingdom and CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM) announces it highlighted the discovery of new mechanism antibiotic candidates for the [...]
Pluristem and Indiana University to Initiate Joint Project Evaluating PLX-R18 in Acute Radiation Syndrome, Targeting Bridging Data for Pivotal Study
23/04/2018
The 5-year joint project was granted $2.5 million from the U.S. National Institutes of Health (NIH) Data from these studies will support BLA filing for marketing approval of PLX-R18 in the treatment of ARS HAIFA, Israel [...]
Axsome Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of AXS-05 in Smoking Cessation
23/04/2018
Trial being conducted in collaboration with Duke University NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a clinical-stage biopharmaceutical company developing novel therapies [...]
Annual Report 2017 Active Biotech AB (publ)
23/04/2018
PRESS RELEASE Active Biotech's Annual Report 2017 is now available för download at www.activebiotech.com . The Annual Report will only be digitally distributed. The English version will be available within short. Lund, [...]
Transactions under Novozymes’ stock buyback program
23/04/2018
Please read the full announcement in the attached PDF Attachment 2018_15_Stock_Buybackprogram_EN
Q Therapeutics Announces Joint Venture With REPROCELL
23/04/2018
PARTNERSHIP WILL DEVELOP IPSC-DERIVED PRODUCTS TO TREAT CENTRAL NERVOUS SYSTEM DISEASES INVOLVING DEMYELINATION AND DEGENERATION SALT LAKE CITY andI YOKOHAMA, Japan, April 23, 2018 (GLOBE NEWSWIRE) -- Q Therapeutics, [...]
Amarin Announces Promotion of Aaron Berg to Position of Chief Commercial Officer
23/04/2018
BEDMINSTER, N.J., and DUBLIN, Ireland, April 23, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]

Pages